George Clinical
An established, fast growing and profitable business with a mission to be a CRO with global service delivery, world-class scientific leadership and therapeutic strengths in oncology, vascular and metabolic disease to improve the health of millions of people worldwide.
We are a leading contract research organization with approximately 300 global staff providing the full range of clinical trial services to pharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials. George Clinical combines scientific and clinical leadership with expert trial delivery to create a distinctive world-class service CRO.
Our parent organization, The George Institute for Global Health, is a leader in chronic disease research, with a global network of experts with whom George Clinical engages. Together we provide an operationally supported, internationally recognized scientific leadership service, bringing together an extensive series of investigator networks, which allows George Clinical to provide customizable clinical trial excellence from trial design through all aspects of delivery.
As clinical trial costs and complexities escalate, our multi-disciplined experts provide customers with innovative solutions to access patient populations and reduce sponsor R&D costs, ensuring that their clinical trials have an impact for clinicians and patients, while maintaining the highest scientific integrity.
Profit with purpose, delivering sustainable impact and attractive returns
Better Treatments, Better Care,
Healthier Societies
New Frontiers
George
Clinical
Science, service, solutions. A leading CRO in Asia-Pacific with Global capabilities
Novel Treatments
George
Medicines
Innovative, affordable treatments for leading causes of death globally
Disruptive technologies
